Revolution Medicines Inc
F:42Z
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Revolution Medicines Inc
F:42Z
|
US |
|
I
|
Industrial and Commercial Bank of China Ltd
SWB:ICK
|
CN |
|
Blue Owl Capital Corp
NYSE:OBDC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
W
|
Wilson Bayly Holmes - Ovcon Ltd
JSE:WBO
|
ZA |
|
Intel Corp
NASDAQ:INTC
|
US |
|
T
|
TechnipFMC PLC
LSE:0RMV
|
UK |
|
ServiceNow Inc
NYSE:NOW
|
US |
|
B
|
Badger Meter Inc
XBER:33B
|
US |
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
DE |
|
Werner Enterprises Inc
F:WE1
|
US |
|
I-Mab
NASDAQ:NBP
|
US |
|
Hisense Visual Technology Co Ltd
SSE:600060
|
CN |
|
Warner Bros Discovery Inc
NASDAQ:WBD
|
US |
|
Banca Popolare Di Sondrio SpA
MIL:BPSO
|
IT |
|
Grindrod Ltd
OTC:GRDLF
|
ZA |
|
B
|
Barclays PLC
F:BCY2
|
UK |
|
Palisade Bio Inc
F:7NS
|
US |
|
CK Hutchison Holdings Ltd
HKEX:1
|
HK |
|
E
|
eBay Inc
SWB:EBA
|
US |
Bankruptcy Probability
Revolution Medicines Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Revolution Medicines Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
29.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
371.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
176.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
160.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
OpGen Inc
NASDAQ:OPGN
|
239.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
73.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Revolution Medicines Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Revolution Medicines Inc has total debt of 268.4m USD. This includes both short-term (0 USD) and long-term (268.4m USD) debt.
You can find a full breakdown on its Balance Sheet.
